Ingliforib
≥99%
- Product Code: 100996
CAS:
186392-65-4
| Molecular Weight: | 457.91 g./mol | Molecular Formula: | C₂₃H₂₄ClN₃O₅ |
|---|---|---|---|
| EC Number: | MDL Number: | ||
| Melting Point: | Boiling Point: | ||
| Density: | Storage Condition: | 2-8℃ |
Product Description:
Ingliforib is primarily investigated for its potential therapeutic applications in the treatment of cancer. It functions as an inhibitor of the enzyme geranylgeranyltransferase I (GGTase-I), which plays a crucial role in the post-translational modification of proteins involved in cell signaling and growth. By inhibiting GGTase-I, Ingliforib disrupts the activation of certain oncogenic proteins, particularly those in the Ras family, which are often implicated in uncontrolled cell proliferation and tumor growth. This mechanism makes it a promising candidate for targeting cancers driven by Ras mutations or other GGTase-I-dependent pathways. Research is ongoing to evaluate its efficacy, safety, and potential use in combination with other anticancer therapies.
Product Specification:
| Test | Specification |
|---|---|
| Appearance | Light Yellow To Yellow Solid |
| Purity (%) | 98.5 |
| Infrared Spectrum | Conforms To Structure |
| NMR | Conforms To Structure |
Sizes / Availability / Pricing:
| Size (g) | Availability | Price | Quantity |
|---|---|---|---|
| 0.005 | 10-20 days | $1,385.24 |
+
-
|
| 0.010 | 10-20 days | $2,308.73 |
+
-
|
Ingliforib
Ingliforib is primarily investigated for its potential therapeutic applications in the treatment of cancer. It functions as an inhibitor of the enzyme geranylgeranyltransferase I (GGTase-I), which plays a crucial role in the post-translational modification of proteins involved in cell signaling and growth. By inhibiting GGTase-I, Ingliforib disrupts the activation of certain oncogenic proteins, particularly those in the Ras family, which are often implicated in uncontrolled cell proliferation and tumor growth. This mechanism makes it a promising candidate for targeting cancers driven by Ras mutations or other GGTase-I-dependent pathways. Research is ongoing to evaluate its efficacy, safety, and potential use in combination with other anticancer therapies.
| Mechanism | - |
| Appearance | - |
| Longevity | - |
| Strength | - |
| Storage | - |
| Shelf Life | - |
| Allergen(s) | - |
| Dosage (Range) | - |
| Recommended Dosage | - |
| Dosage (Per Day) | - |
| Recommended Dosage (Per Day) | - |
| Mix Method | - |
| Heat Resistance | - |
| Stable in pH range | - |
| Solubility | - |
| Product Types | - |
| INCI | - |
Cart
No products
Subtotal:
$0.00
$0.00
Total :